Migliore Federico, Mattesi Giulia, Zorzi Alessandro, Viani Stefano, Bongiorni Maria Grazia, Francia Pietro, Curcio Antonio, Diemberger Igor, Bertaglia Emanuele
Dipartimento Cardio-Toraco-Vascolare, Università degli Studi, Padova.
U.O. Malattie Cardiovascolari 2, Azienda Ospedaliero-Universitaria Pisana, Pisa.
G Ital Cardiol (Rome). 2019 Nov;20(11):641-650. doi: 10.1714/3254.32225.
Overcoming lead-related complications, the subcutaneous implantable cardioverter-defibrillator (S-ICD) represents the greatest advancement in the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Due to the absence of leads within the body, the S-ICD requires an innovative approach for sensing of subcutaneous signals and defibrillation. The aim of this review is to analyze the current evidence regarding patient selection, technical aspects such as the implant technique, programming and follow-up, as well as complications and troubleshooting of this innovative technology.
皮下植入式心律转复除颤器(S-ICD)克服了与导线相关的并发症,代表了室性心律失常患者管理和心脏性猝死预防方面的最大进展。由于体内没有导线,S-ICD需要一种创新方法来感知皮下信号和进行除颤。本综述的目的是分析有关患者选择的当前证据、植入技术、编程和随访等技术方面,以及这项创新技术的并发症和故障排除。